Jennison Associates
BIO icon

Jennison Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jennison Associates’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66,234
Closed -$27.6M – 581
2022
Q3 		$27.6M Buy
66,234
+1,399
+2% +$698K 0.03% 271
2022
Q2 		$32.1M Sell
64,835
-3,026
-4% -$1.58M 0.03% 238
2022
Q1 		$38.2M Buy
67,861
+15,638
+30% +$9.43M 0.03% 260
2021
Q4 		$39.5M Buy
52,223
+41
+0.1% +$30.7K 0.03% 262
2021
Q3 		$38.9M Buy
52,182
+22,922
+78% +$17.2M 0.03% 254
2021
Q2 		$18.9M Buy
29,260
+7,402
+34% +$4.5M 0.01% 376
2021
Q1 		$12.5M Buy
21,858
+6,975
+47% +$4.13M 0.01% 403
2020
Q4 		$8.68M Buy
14,883
+5,278
+55% +$3.01M 0.01% 419
2020
Q3 		$4.95M Buy
9,605
+3,361
+54% +$1.7M ﹤0.01% 438
2020
Q2 		$2.82M Buy
6,244
+4,329
+226% +$1.91M ﹤0.01% 453
2020
Q1 		$671K Buy
+1,915
New +$704K ﹤0.01% 524

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return